ClinicalTrials.Veeva

Menu

H+ Mobilization With Dialysate Bicarbonate Variation

Tufts University logo

Tufts University

Status and phase

Terminated
Phase 2

Conditions

Chronic Kidney Disease

Treatments

Dietary Supplement: Zone Perfect bar
Device: variation in dialysis bicarbonate

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The aims of the proposed studies are first to delineate the physiological response of End Stage Kidney Disease (ESKD) patients to exposure to a bath [HCO3-] of 35 mEq/L and an [acetate] of 4 mEq/L, and second, to determine whether reducing bath [HCO3-] will have the expected effect of decreasing or abolishing stimulation of organic acid production. A secondary endpoint will be whether the patients tolerate such a reduction and its impact on pre-dialysis blood [HCO3-]. If the outcome is positive in both regards, future studies will measure well-being and outcomes with reduced bath [HCO3-].

Enrollment

13 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients must be 18 years or older,
  2. Have been on dialysis for at least 1 year,
  3. Be stable on treatment (i.e., without frequent changes in their dialysis prescription, or recent hospitalizations),
  4. Be reasonably nourished (serum albumin > 3.5 g/dl and not currently receiving oral nutritional supplement through DCI).
  5. Self-reported urine output of <200 cc/day
  6. Functioning arteriovenous fistulas or grafts for dialysis access
  7. Currently dialyzing at a dialysate [HCO3-] of 33-37 mEq/L.

Exclusion criteria

  1. Pregnancy,
  2. Acute illnesses of any kind,
  3. Hospitalization in the prior 3 months (except for vascular access related),
  4. Significant congestive heart failure, liver or lung failure.
  5. Pre-dialysis blood [HCO3-] <19 mEq/L) (to reduce the risk of metabolic acidosis )

Trial design

13 participants in 1 patient group

Bicarb Variation
Other group
Description:
Variation in dialysis bicarbonate, lowered to 30 mEq/L for week 2 of 3
Treatment:
Device: variation in dialysis bicarbonate
Dietary Supplement: Zone Perfect bar

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems